Buy Any Report Avail 20% Discount

Global Coronavirus Vaccine Market 2019 - Industry Analysis, Size, Share, Growth, Trends and Forecast 2025

Coronavirus Vaccine Market is expected to witness lucrative growth from 2019 to 2025

Coronaviruses are a group of viruses that can produce infections or diseases. Human coronaviruses, abbreviated as HCoV, were detected in the early 1960s. Indications of these viruses range from common cold to severe infections and serious respiratory complications, pneumonia, and eventually kidney failure and death. These infections are common among individuals with heart disease, people with fragile immune system, kids, and old people. 

The 2019-nCoV also called as the Wuhan coronavirus, is very contagious and leads to severe respiratory infections. This virus was initially identified by healthcare authorities in Wuhan, China in 2019, due to the ongoing coronavirus outbreak in the city. Reports stated that Wuhan coronavirus had epidemiological link to seafood and animals, owing to which, this virus is understood to possibly have zoonotic cause, though it has not been verified yet. 2019-nCoV, when compared to genetic sequences of other existing viruses, has shown some resemblances to SARS-CoV of around 79.5% as well as 96% resemblances to bat coronaviruses.

Key Market Trends

Technological advancements
Technological advancements in the pharmaceutical sector consist of development of nucleic acid vaccines that are based on DNA- and RNA, and which allow the human body to generate vaccine antigen. Such kind of development is projected to boost market growth to a noteworthy extent. For instance, in January 2020, Inovio Pharmaceuticals, Inc. announced that the Coalition for Epidemic Preparedness Innovations (CEPI) has awarded Inovio a funding of up to US$9 million. To create a vaccine counter to novel developed strain of coronavirus (2019-nCoV) that has infested and destroyed numerous people

Rising demand in developing countries
The 2019 – 2020 epidemic in Wuhan City, China, and its quick spread across various countries in Asia Pacific is anticipated to endanger millions of lives. This has provoked a burst of activity in an order to develop a vaccine. In addition, replacement of stocks of medicine that will be required to treat symptoms caused by the virus is currently in full swing at major companies. Demand for vaccines and other related products is rising quickly as countries around the globe prepare for a potential outbreak.

Competitive Landscape:

Some of the major market players operating in global Coronavirus Vaccine market are Inovio Pharmaceuticals, Inc., Moderna, Inc., Novavax, Inc., Protein Potential, LLC, AlphaVax, Inc., Synairgen PLC, NanoViricides, Inc., GGeneCure, LLC Clover Biopharmaceuticals, Vaxart. Major companies are focusing on collaborations, agreements and joint ventures to increase their market presence. Also they are focusing on novel product launches to fortify product portfolio and acquire higher market share in the Coronavirus Vaccine market.

• Scope of the Report

Base Year for Estimation

2019

Forecast Period

2020–2025

Forecast units

Value (USD Million)

Regional Scope

North America, Asia Pacific, Europe, Latin America, and Middle East & Africa

Countries Covered

U.S.A, Canada, Mexico, U.K., Germany, Spain, Italy, France, China, India, & Japan

Coronavirus Vaccine Market, By Vaccine type  

 

Inactivated coronavirus vaccine, Live attenuated coronavirus vaccine, S-Protein based coronavirus vaccine

Coronavirus Vaccine Market, By Infection Type

HCoV-229E, HCoV-OC43, SARS-CoV, New Haven CoV, HKU1-CoV, MERS-CoV

Coronavirus Vaccine Market, By End use

Hospitals, Clinics, Others

 

Companies covered

Inovio Pharmaceuticals, Inc., Moderna, Inc., Novavax, Inc., Protein Potential, LLC, AlphaVax, Inc., Synairgen PLC, NanoViricides, Inc., GGeneCure, LLC Clover Biopharmaceuticals, Vaxart


Questions addressed in the report
• Where will all these developments take the industry in the mid to long-term?
• What are the upcoming industry applications for the Coronavirus Vaccine market?
• Which segment provides the most opportunity for growth?
• Which are the leading vendors operating in this market?
• What are the opportunities for new market entrants?

• By Infection Type
o HCoV-229E
o HCoV-OC43
o SARS-CoV
o New Haven CoV
o HKU1-CoV
o MERS-CoV

• By Vaccine Type
o Inactivated coronavirus vaccine
o Live attenuated coronavirus vaccine
o S-Protein based coronavirus vaccine

• By End use
o Hospitals
o Clinic
o Others

• By Region
o North America
o Europe
o Asia-Pacific
o Latin America
o Middle East & Africa

• Company Coverage
o Inovio Pharmaceuticals, Inc.
o Moderna, Inc.
o Novavax, Inc.
o Protein Potential, LLC
o AlphaVax, Inc.
o Synairgen PLC
o NanoViricides, Inc.
o GGeneCure, LLC
o Clover Biopharmaceuticals
o Vaxart

Table of Contents

Introduction
Objectives of the Study
Market Definition
Coronavirus Vaccine Market Covered
Years Considered for the Study
Currency
Stakeholders

Research Methodology
Primary Data
Key Data From Primary Sources
Key Industry Insights
Secondary Data
Key Data From Secondary Sources
Market Breakdown and Data Triangulation
Assumptions for the Study

Executive Summary

Market Overview
Introduction
Market Dynamics
Drivers
Opportunities
Emerging Markets

Coronavirus Vaccine Market, by Infection Type
Introduction
HCoV-229E
HCoV-OC43
SARS-CoV
New Haven CoV
HKU1-CoV
MERS-CoV

Coronavirus Vaccine Market, by Vaccine type
Introduction
Inactivated coronavirus vaccine
Live attenuated coronavirus vaccine
S-Protein based coronavirus vaccine

Coronavirus Vaccine Market, by End use
Introduction
Hospitals
Clinics
Others

Coronavirus Vaccine Market, By Country
North America
U.S.
Canada
Europe
U.K.
Germany
Spain
France
Italy
Asia Pacific
China
Japan
India

Competitive Landscape
Market Overview
Product Launches and Approvals
Agreements, Partnerships, and Collaborations
Mergers and Acquisitions
Expansions

Company Profiles
Inovio Pharmaceuticals, Inc.
Moderna, Inc.
Novavax, Inc.
Protein Potential, LLC
AlphaVax, Inc.
Synairgen PLC
NanoViricides, Inc.
GGeneCure, LLC
Clover Biopharmaceuticals
Vaxart


Inovio Pharmaceuticals, Inc.
Moderna, Inc.
Novavax, Inc.
Protein Potential, LLC
AlphaVax, Inc.
Synairgen PLC
NanoViricides, Inc.
GGeneCure, LLC
Clover Biopharmaceuticals
Vaxart
Shop Now
Buy Now
Why Inside Market Reports
  • Explore extensive library of market reports
  • Accurate and Actionable insights
  • Focus on Key Trends and Market Movements
  • Critical Consulting Project Execution
  • 24/7 Online and Offline Support
  • Most-detailed market segmentation
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays